Want to see IL:SOFW full AI Analyst Report?
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range2,399.00 - 4,869.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.63B
Enterprise Value459.88M
Total Cash (Recent Filing)₪35.49M
Total Debt (Recent Filing)₪1.43M
Price to Earnings (P/E)65.2
Beta0.69
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding36,348,373
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSofwave's ~75% gross margin indicates durable unit economics from its energy-based device platform and consumables. High gross margins provide pricing power and margin buffer to invest in R&D, distribution, and service infrastructure, supporting sustained profitability over time.
Very Low Financial LeverageA near-zero debt-to-equity ratio and modest absolute debt give the company strong financial flexibility. Low leverage reduces bankruptcy risk, lowers interest burden, and enables management to fund growth, buybacks, or opportunistic investments without tight liquidity constraints.
Strong Free Cash Flow GenerationTransition to sustained positive operating and free cash flow demonstrates real cash-generative operations and earnings quality. Positive FCF supports reinvestment in installed base expansion, consumable sales, and service growth while enabling a conservative capital structure over the medium term.
Bears Say
Uneven Revenue GrowthRevenue growth has been inconsistent, with near-flat growth in 2025 then improving to mid-single digits TTM. This unevenness raises risk that topline momentum could stall again, making future margin and cash-flow outcomes more dependent on execution and sustained adoption.
Cash Conversion / Working-capital DragAlthough absolute cash flow is strong, operating cash flow trails net income on a coverage basis, implying working-capital timing or collection issues. Persistent cash conversion gaps could constrain reinvestment or require financing if they widen during growth phases.
Equity Base Below Pre-loss LevelsThe capital base has not fully recovered to 2021 equity levels after prior losses, leaving less cushion for adverse shocks. A smaller equity buffer could limit flexibility for large investments or acquisitions and raises sensitivity to future downturns despite current profitability.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 2399.00 and its highest was 4869.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.63B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 21 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on May 05, 2026. The company reported 10.9 earnings per share for the quarter, beating the consensus estimate of N/A by 10.9.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,348,373 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 10.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.99%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Founded in 2015, Sofwave Medical Ltd. is an Israeli company dedicated to developing cutting-edge ultrasound technology. This technology is employed for the non-invasive treatment of fine lines and wrinkles, with the company's reach extending to physicians both in Israel and internationally. Headquartered in Yokne'am Illit, Israel, they provide advanced aesthetic medical devices for skin care.